Integra LifeSciences Operating Profit Margin History

IART Stock  USD 8.94  0.04  0.45%   
Operating Profit Margin came in at 0.04 for Integra LifeSciences, representing a 4.83% increase from the prior year's 0.04. Integra LifeSciences' Operating Profit Margin is on a recovering trend.

Latest Integra LifeSciences' Operating Profit Margin Growth Pattern

Over 15 reporting periods, Integra LifeSciences' Operating Profit Margin has trended recovering. With Operating Profit Margin at 0.04, the latest period is above the prior year's 0.04. Steeper segments in Integra LifeSciences' Operating Profit Margin chart indicate periods of accelerated change.
Operating Profit Margin10 Years Trend
Slightly volatile
All values are based on reported financial data and presented for reference.
   Operating Profit Margin   
       Timeline  

Operating Profit Margin Trend Statistics

Arithmetic Mean 0.03
Geometric Mean 0.07
Coefficient Of Variation 479.92
Mean Deviation 0.08
Median 0.07
Standard Deviation 0.17
Sample Variance 0.03
Range0.7416
R-Value 0.39
Mean Square Error 0.02
R-Squared 0.16
Significance 0.12
Slope 0.01
Total Sum of Squares 0.44

Integra LifeSciences Operating Profit Margin History

2026 0.0439
2025 0.0418
2024 0.0176
2023 0.0723
2022 0.15
2021 0.13
2020 0.11
2019 0.0618
2018 0.0754
2017 0.0377
2016 0.12
2015 0.0902
2014 0.0706
2013 -0.004358
2012 0.0888

Related Accounts

Methodology, Assumptions & Data Sources

Below you can see Integra LifeSciences's Operating Profit Margin across recent years. Big swings can signal sensitivity to the broader economy.

Macroaxis compiles Integra LifeSciences Holdings metrics from periodic company reporting and market reference feeds and applies consistent transformation rules before display. Not all fields update in real time. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board
Last reviewed on March 5th, 2026